Nvidia and Palantir have both witnessed enormous valuation expansion throughout the artificial intelligence (AI) revolution.

With market caps in the trillions, these tech behemoths are establishing a growing presence in drug development. Here’s what ...

Funds own 41% of Nvidia's outstanding shares, according to IBD MarketSurge. Going by its Accumulation/Distribution Rating of ...

Nvidia’s next major platform isn’t just a fancy new nickname, but it’s perhaps the next AI growth cycle. “Vera Rubin” ...

Nvidia stock (NASDAQ: NVDA) has been propelled by a 40.5% year-to-date rally, underpinned by surging data-center demand and ...

Nvidia’s sales of its artificial intelligence chipsets remained a hot commodity during the company’s latest quarter, but the ...

Long-term investors can benefit from picking stakes in core artificial intelligence (AI) infrastructure players besides ...

Two of the most widely recognized names in technology are collaborating to expand the reach of artificial intelligence (AI).

Nvidia CEO Jensen Huang says the U.S. is entering an AI-powered industrial revolution, crediting President Donald Trump's ...

Nvidia founder and CEO Jensen Huang says Friday's unveiling of a U.S.-made Blackwell wafer to make artificial intelligence ...

From xAI to OpenAI to CoreWeave, Nvidia is building AI’s infrastructure, although missed chances are piling up.

This hope for the future while discounting the present has taken Tesla’s market valuation to dizzying heights.